For clinicians and patients building a precision longevity protocol, the central question is no longer whether MOTS-c matters, but how to dose it correctly
Confusing topical and injectable doses
Plotkin, L
Wegovy tablets and injections are FDA-approved in adults for: weight loss and weight management in adults with obesity or adults who are overweight and have a weight-related medical problem (e.g., blood pressure, type 2 diabetes, or high cholesterol) reducing major cardiovascular event risks (such as heart attack, stroke, or death) in adults with established CV disease and either obesity or overweight Wegovy injection is also FDA-approved for: weight loss and weight management patients with obesity who are 12 years and older non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), this is an accelerated approval
These procedures may include recording access dates, maintaining inventory logs, and monitoring storage conditions in accordance with internal quality standards
Because the presenting complaints are often prominent in relation to one of the three organ systems, physicians are frequently misled